FDA fast track designation granted to Zentylor for Progressive Supranuclear Palsy (PSP) - MPR
Links shared publicly online about this topic.
- 876total visits
FDA fast track designation granted to Zentylor for Progressive Supranuclear Palsy (PSP) - MPR
empr.com —
View full resource at empr.com
Most Recently Shared on September 13, 2010 at 3:59 pm By:
MPR News: FDA fast track designation granted to Zentylor for Progressive Supranuclear Palsy (PSP): Noscira announc... http://bit.ly/bBDsDM
Noscira receives FDA approval for Tideglusib drug to treat PSP
news-medical.net — “Noscira, a Grupo Zeltia subsidiary specialized in research and development of drugs to treat neurodegenerative diseases, has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track status to its neuroprotector drug Tideglusib (ZentylorTM) to treat Progressive Supranuclear Palsy (PSP), a fast-advancing fatal degenerative brain disorder.” View full resource at news-medical.net
Most Recently Shared on September 10, 2010 at 6:38 am By:
Noscira receives FDA approval for Tideglusib drug to treat PSP: Noscira, a Grupo Zeltia subsidiary specialized in ... http://bit.ly/aofZPY
Advertisement
